Elanco, the animal health division of Eli Lilly and Co., received final approval from the European Commission to close its acquisition deal with the animal health business of Janssen Pharmaceutica NV.

The acquisition continues Elanco’s growth in Europe and will allow customers access to a broader range of animal health products and services.